CLOs on the Move

Bayer Pharmaceutical Manufacturing Services

www.bayerpharmamfgservices.com

 
Bayer Pharmaceutical Manufacturing Services is a Shawnee, KS-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Lila Natural Cosmetics

Lila Natural Cosmetics is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Med-Response Inc

Med-Response Inc is a Bluefield, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GoHealth Urgent Care

GoHealth Urgent Care is one of the countrys fastest-growing and largest urgent care providers. At GoHealth Urgent Care, we place the needs of our patients first—by providing an effortless patient experience, a welcoming culture of care and seamless integration with market-leading health systems and our communities. GoHealth Urgent Care operates 80 urgent care centers in the New York and Portland, Oregon, metropolitan areas, the San Francisco Bay Area, Hartford, Connecticut, and will soon open urgent care centers in multiple Midwest markets. GoHealth Urgent Cares current partners include health systems that are at the forefront of care delivery innovation, including Northwell Health, New Yorks largest health system, Legacy Health, the largest nonprofit, locally owned health system in the Portland-Vancouver area, Dignity Health, one of the nations largest health care systems, headquartered in San Francisco, Hartford HealthCare, Connecticuts most comprehensive health care network, and now Mercy, one of the Midwests largest, most integrated and innovative health systems.

Ovid Therapeutics

Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.

Belong.Life

Belong is the world`s largest digital social network for cancer patients and caregivers.